ArticleFrontiers in oncology2025
AI-augmented pathology: the experience of transfer learning and intra-domain data diversity in breast cancer metastasis detection.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Ovarian tissue quality assessment and fertility preservation strategies enabled by multi-omics and artificial intelligence: current applications and clinical perspectives.Frontiers in physiology · 2026Review
- Toward Artificial Intelligence in Oncology and Cardiology: A Narrative Review of Systems, Challenges, and Opportunities.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Metastatic detection in sentinel lymph nodes remains a crucial prognostic factor in breast cancer management, with accurate and timely diagnosis directly impacting treatment decisions. While traditional histopathological assessment relies on microscopic examination of stained tissues, the digitization of slides as whole-slide images (WSI) has enabled the development of computer-aided diagnostic systems. These automated approaches offer potential improvements in detection consistency and efficiency compared to conventional methods. Results: This study leverages transfer learning on hematoxylin and eosin (HE) WSIs to achieve computationally efficient metastasis detection without compromising accuracy. We propose an approach for generating segmentation masks by transferring spatial annotations from immunohistochemistry (IHC) WSIs to corresponding H&E slides. Using these masks, four distinct datasets were constructed to fine-tune a pretrained ResNet50 model across eight different configurations, incorporating varied dataset combinations and data augmentation techniques. To enhance interpretability, we developed a visualization tool that employs color-coded probability maps to highlight tumor regions alongside their prediction confidence. Our experiments demonstrated that integrating an external dataset (Camelyon16) during training significantly improved model performance, surpassing the benefits of data augmentation alone. The optimal model, trained on both external and local data, achieved an accuracy and F1-score of 0.98, outperforming existing state-of-the-art methods. Conclusions: This study demonstrates that transfer learning architectures, when enhanced with multi-source data integration and interpretability frameworks, can significantly improve metastatic detection in whole slide imaging. Our methodology achieves diagnostic performance comparable to gold-standard techniques while dramatically accelerating analytical workflows. The synergistic combination of external dataset incorporation and probabilistic visualization outputs provides a clinically actionable solution that maintains both computational efficiency and pathological interpretability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.